Overview / Abstract: |
The continued evolution of diagnostic, therapeutic, and surgical algorithms for the management of patients with retinal diseases offer the potential for enhancing visual, anatomical, and quality-of-life outcomes in these patients. Recognition, understanding, and application of these evidence-based advances are imperative to enhance treatment outcomes and patient satisfaction. During Part 1 of this 2-part educational activity, updates in state-of-the-art management strategies for neovascular age-related macular degeneration, diabetic eye disease, and retinal vein occlusion will be discussed. |
Expiration |
Nov 09, 2025 |
Discipline(s) |
Optometry / Ophthalmology CE |
Format |
Webinar / Webcast / Video |
Credits / Hours |
2 |
Accreditation |
This continuing education activity is provided by Vindico Medical Education. |
Presenters / Authors / Faculty |
Rishi P. Singh, MD John B. Miller, MD Yasha Modi, MD |
Sponsors / Supporters / Grant Providers |
This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc.; Genentech, a member of the Roche Group.; Neurotech Pharmaceuticals, Inc.; Astellas; EyePoint Pharmaceuticals, Inc.; Opthea Ltd.; Topcon Healthcare, Inc.; Outlook Therapeutics; REGENXBIO Inc.; Ocuphire Pharma; and Carl Zeiss Meditec, Inc. |
Keywords / Search Terms |
Vindico Medical Education vindico, cme, healio, ophthalmology, namd, rvo Free CE CME |